Gene Group Limited - Accounts to registrar (filleted) - small 18.2

Gene Group Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.1.1.57 08861627 Board of Directors 1.1.18 31.12.18 31.12.18 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure088616272017-12-31088616272018-12-31088616272018-01-012018-12-31088616272016-12-31088616272017-01-012017-12-31088616272017-12-3108861627ns15:EnglandWales2018-01-012018-12-3108861627ns14:PoundSterling2018-01-012018-12-3108861627ns10:Director12018-01-012018-12-3108861627ns10:PrivateLimitedCompanyLtd2018-01-012018-12-3108861627ns10:SmallEntities2018-01-012018-12-3108861627ns10:AuditExempt-NoAccountantsReport2018-01-012018-12-3108861627ns10:SmallCompaniesRegimeForDirectorsReport2018-01-012018-12-3108861627ns10:SmallCompaniesRegimeForAccounts2018-01-012018-12-3108861627ns10:FullAccounts2018-01-012018-12-3108861627ns10:Director22018-01-012018-12-3108861627ns10:Director32018-01-012018-12-3108861627ns10:CompanySecretary12018-01-012018-12-3108861627ns10:RegisteredOffice2018-01-012018-12-3108861627ns5:CurrentFinancialInstruments2018-12-3108861627ns5:CurrentFinancialInstruments2017-12-3108861627ns5:ShareCapital2018-12-3108861627ns5:ShareCapital2017-12-3108861627ns5:RetainedEarningsAccumulatedLosses2018-12-3108861627ns5:RetainedEarningsAccumulatedLosses2017-12-3108861627ns5:PlantMachinery2017-12-3108861627ns5:PlantMachinery2018-01-012018-12-3108861627ns5:PlantMachinery2018-12-3108861627ns5:PlantMachinery2017-12-3108861627ns5:CostValuation2017-12-3108861627ns5:AdditionsToInvestments2018-12-3108861627ns5:CostValuation2018-12-3108861627ns5:Subsidiary12018-01-012018-12-31088616271ns5:Subsidiary12018-01-012018-12-3108861627ns5:Subsidiary12018-12-3108861627ns5:Subsidiary12017-12-3108861627ns5:Subsidiary12017-01-012017-12-3108861627ns5:Subsidiary22018-01-012018-12-31088616273ns5:Subsidiary22018-01-012018-12-31088616274ns5:Subsidiary22018-01-012018-12-3108861627ns5:Subsidiary22018-12-3108861627ns5:Subsidiary22017-12-3108861627ns5:Subsidiary22017-01-012017-12-3108861627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-12-3108861627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-12-31


REGISTERED NUMBER: 08861627 (England and Wales)













FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2018

FOR

GENE GROUP LIMITED

GENE GROUP LIMITED (REGISTERED NUMBER: 08861627)






CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2018




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


GENE GROUP LIMITED

COMPANY INFORMATION
For The Year Ended 31 December 2018







DIRECTORS: N A Edelman
G S Edelman
P J E Holt





SECRETARY: P J E Holt





REGISTERED OFFICE: 68 Verran Road
Camberley
Surrey
GU15 2LJ





REGISTERED NUMBER: 08861627 (England and Wales)





ACCOUNTANTS: Kirk Rice LLP
13 Princeton Court
53 - 55 Felsham Road
Putney
London
SW15 1AZ

GENE GROUP LIMITED (REGISTERED NUMBER: 08861627)

BALANCE SHEET
31 December 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 36 209
Investments 5 275 225
311 434

CURRENT ASSETS
Debtors 6 110,882 86,840
Cash at bank 3,180 25,160
114,062 112,000
CREDITORS
Amounts falling due within one year 7 109,820 147,589
NET CURRENT ASSETS/(LIABILITIES) 4,242 (35,589 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,553

(35,155

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 4,453 (35,255 )
SHAREHOLDERS' FUNDS 4,553 (35,155 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable
to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 29 July 2019 and were signed on its behalf by:





P J E Holt - Director


GENE GROUP LIMITED (REGISTERED NUMBER: 08861627)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2018

1. STATUTORY INFORMATION

Gene Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered
number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added
tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

- Fixtures and Fittings - 25% on cost.
- Computer Equipment - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that
it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively
enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in
which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted
or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be
recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2017 - 4 ) .

GENE GROUP LIMITED (REGISTERED NUMBER: 08861627)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2018

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2018
and 31 December 2018 2,789
DEPRECIATION
At 1 January 2018 2,580
Charge for year 173
At 31 December 2018 2,753
NET BOOK VALUE
At 31 December 2018 36
At 31 December 2017 209

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 January 2018 225
Additions 50
At 31 December 2018 275
NET BOOK VALUE
At 31 December 2018 275
At 31 December 2017 225

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Revolution Technology Limited
Registered office:
Nature of business:
%
Class of shares: holding
A Ordinary 100.00
2018 2017
£    £   
Aggregate capital and reserves (37,400 ) 52
Profit/(loss) for the year 90,272 (37,451 )

Revolution Financial Limited
Registered office:
Nature of business:
%
Class of shares: holding
A Ordinary 100.00
B Ordinary 100.00
2018 2017
£    £   
Aggregate capital and reserves (133,033 ) (74,352 )
Loss for the year - (58,681 )

GENE GROUP LIMITED (REGISTERED NUMBER: 08861627)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2018

5. FIXED ASSET INVESTMENTS - continued

The company owns 75% of the issued share capital (100 £1 ordinary shares) of Revolution Technology Limited, a UK
incorporated trading company.

The company owns 100% of the issued share capital (150 £1 ordinary shares) of Revolution Financial Limited, a UK
incorporated trading company.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 25,735 2,055
Amounts owed by group undertakings 77,285 77,785
Other debtors 7,862 7,000
110,882 86,840

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade creditors (890 ) 2,390
Taxation and social security (3,491 ) (3,835 )
Other creditors 114,201 149,034
109,820 147,589